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The phenomenon of cutaneous diseases sparing
sites of previous trauma has been described, al-
though there are few case reports that illustrate this
rare phenomenon. We report an unusual case of
leukocytoclastic vasculitis (LCV) that completely
spared tattooed skin with an additional halo effect
around the tattoo.
CASE REPORT
A man in his 40s with recent intravenous drug use
and hepatitis C was admitted to the medical intensive
care unit with progressive respiratory failure in
the setting of multifocal pneumonia, an epidural
abscess, tricuspid valve endocarditis, oxacillin-
sensitive Staphylococcus aureus bacteremia, and
acute hepatorenal failure. Laboratory values on
admission were notable for a white blood cell count
of 20 K/L, a hemoglobin level of 11.3 g/dL, in-
ternational normalized ratio of 1.7, platelets of
30 K/L, creatinine level of 6 mg/dL, and total
bilirubin of 17.2 mg/dL. During his hospital stay, he
received multiple antibiotics (levofloxacin, ceftriax-
one, piperacillin-tazobactam, and nafcillin) and
additional new medications (octreotide, pantopra-
zole, albumin, furosemide, lactulose). The patient
had no known history of drug allergies. On day
5 postadmission, nonretiform, palpable purpura
(Fig 1) developed consisting of well-defined, non-
blanching, coalescing, 2- to 3-mm bright red to
purple macules and papules primarily involving
the legs. No splinter hemorrhages, stellate lesions,
ulcerations, or blisters were noted. No additional
symptoms were elicited, as the patient was intu-
bated. Interestingly, the eruption exhibited a
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u2@bidmc.harvard.edu.clinically normal skin around his tattoos (Fig 2, A
and B). Laboratory data showed a hepatitis C viral
load of 323,000 IU/mL. Cryoglobulins, antinuclear
antibody, anti-neutrophil cytoplasmic antibodies,
anti-mitochondrial antibody, and antiesmooth mus-
cle antibody test results were all normal. A skin
biopsy found a superficial perivascular neutrophilic
infiltrate with sparse leukocytoclasis, red blood cell
extravasation, and reactive vascular changes with
complement C3 deposition, consistent with LCV
(Fig 3). The etiology was presumed to be secondary
to nafcillin, given the known association between
penicillins and LCV1 and the appearance of the
rash 5 days after nafcillin was initiated. As a result,
his nafcillin was discontinued and vancomycin
started instead. By day 14 postadmission, the vascu-
litis was almost fully resolved without any further
interventions.
DISCUSSION
LCV is an acute neutrophilic small vessel vasculitis
resulting from vascular deposition of circulating
immune complexes and subsequent activation of
the complement cascade. This activation results in
neutrophil chemotaxis and microvascular injury.2
Clinically, LCV is characterized by palpable purpura,
although less common findings can include urticarial
plaques, vesicles, bullae, and pustules. LCV can be
secondary to a variety of agents including medica-
tions, chemicals, infections, or underlying systemic
disease; however, up to 60% of cases are idiopathic.2JAAD Case Reports 2015;1:269-71.
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Fig 2. Palpable purpura exhibiting a ‘‘sparing phenome-
non’’ with a 2- to 3-cm halo around a tattoo on the (A) right
anterior thigh and (B) right anterior leg.
Fig 1. Extensive nonretiform palpable purpura on bilat-
eral lower extremities.
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270 Chen et alHere we report, to our knowledge, an unusual
case of LCV with sparing of tattooed skin to produce
a ‘‘halo.’’ The phenomenon of one skin disease
sparing the site of a previous skin condition has
been recognized since 1981, when Cochran and
Wilkin3 reported a case of a drug rash failing to
appear in a previously irradiated site on a 12-year-old
girl. Since then, various related terms have been used
to describe this phenomenon, including the reverse
Koebner phenomenon (nonappearance or disap-
pearance of skin lesions at sites of trauma)4 and
Wolf’s isotopic nonresponse (absence of a cutaneous
eruption at the site of another unrelated and already
healed skin disease).5 Although the exact mecha-
nisms and pathophysiology behind these sparing
phenomena are unknown, current hypotheses sug-
gest that alterations in the local structure or immu-
nologic microenvironment at these sites may play a
role.6
To date, few articles report on sparing phenom-
enon in association with LCV. In 2011, Yadav et al7
reported a case of reverse Koebner phenomenon in a
bandage-covered area in a patient with cutaneous
small vessel immune complex vasculitis. The authors
suggested that the sparing phenomenon may have
been a result of diminished blood flow to the dermis
secondary to mechanical pressure from the bandage
and consequent failure of immune complex deposi-
tion. In 2014, Pinal-Fernandez and Solans-Laque8
reported a case of relative sparing of a purpuric
rash over tattooed skin, although the purpuric rash
still extended several centimeters into the areademarcated by the tattoo. The authors proposed
several etiologic explanations for the sparing phe-
nomenon over tattooed skin. These included the
use ofHamamelis virginiana, a component of tattoo
ink with known antietumor necrosis factor and
antiereactive oxygen species properties that may
have had an inhibitory effect on the development of
vasculitis, the potential of the tattoo dye to act as a
photoprotective factor against light penetration into
the dermis, and microvascular changes caused by
tattooing.
Fig 3. High-power image of a routine section. There is a
superficial dermal and predominantly neutrophilic peri-
vascular infiltrate with sparse leukocytoclasis and red
blood cell extravasation, consistent with a leukocytoclastic
vasculitis. (Hematoxylin and eosin stain; original magnifi-
cation: 3290.)
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Chen et al 271In this case, purpura not only spared the multiple
tattoos but exhibited a unique halo effect of 2 to 3 cm
of clinically normal skin surrounding the tattoos. The
term halo is extrapolated from its use in the halo
nevus where local immunologic changes account for
perinevoid vitiligo. In the case of LCV, the halo effect
could reflect local immunologic changes of the
dermis caused by tattooing that inhibit neutrophil
migration and subsequent cytokine cascade. The
patient’s tattoos were self-administered 20 years pre-
viously using ink made from burned plastic ashes,
Colgate toothpaste, and Alberto VO5 shampoo.
Fluoride in animal and human studies has been
found to affect immune function through observed
effects on T regulatory cells and neutrophils.9,10
Given the important role of neutrophil migration in
effecting an immune response, we hypothesize thatthe introduction of fluoride into the dermis through
toothpaste may account for some degree of the
observed halo effect. Distortion or destruction of
postcapillary venules as a consequence of tattooing
may also have a contributory effect. Further studies
are required to elucidate the pathogenesis behind
this novel phenomenon of LCV sparing a tattoo with
halo effect.
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